ARTICLES BY THIS AUTHOR
- 1/9/2023
Giant kicks off 3rd annual Feeding School Kids initiative
Giant, Martin’s and Giant Heirloom Market store customers are invited to round up their grocery purchases to the nearest dollar or convert their CHOICE points into a donation. - 1/9/2023
Rite Aid names Elizabeth “Busy” Burr interim CEO
Heyward Donigan is departing from the company as president and CEO. - 1/9/2023
Novartis to pay $245M to end antitrust litigation over generic Exforge
Novartis AG agreed to pay $245 million to end antitrust litigation accusing the company of trying to delay the launch of generic versions of the drug Exforge in the United States. - 1/4/2023
AAM applauds Consolidated Appropriations Act of 2023
The Consolidated Appropriations Act will increase competition from generic and biosimilar medicines and enhance patient access to lower cost prescription drugs. - 1/3/2023
Female surgeon creates revolutionary OTC product
Gail Lebovic’s recent move in health care came in 2020, with the formation of Silicon Valley Innovations, and its OTC flagship product, NasoClenz. - 1/3/2023
Vanda provides update to Hetlioz ANDA litigation appeal
The United States Court of Appeals for the Federal Circuit has granted a motion to temporarily enjoin the generic launch by Teva and Apotex of Hetlioz. - 12/29/2022
2022 DSN Industry Issues Summit panel weighs in on why shoppers need pharmacy more than ever
The second panel at Drug Store News’ 24th annual Industry Issues Summit explored how retailers and pharmacy technology companies are responding to customers’ and patients’ needs. - 12/29/2022
Amneal touts 26 generic new product launches in 2022
The company successfully launched 26 new generic products in 2022. - 12/29/2022
How is tripledemic affecting OTC sales of flu, RSV remedies?
Catalina’s Shopper Intelligence data shows a sharp increase in OTC flu, RSV treatment unit sales as prices rise. - 12/29/2022
Parexel partners with MyEyeDr. to increase patient participation in ophthalmology clinical trials
The new collaboration leverages MyEyeDr.’s 850+ offices to refer patients into ophthalmology clinical trials.